These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 74883)

  • 1. Cell-mediated lympholysis in man: identification of a common target determinant associated with HLA-B12 and Bw35.
    Schendel DJ; Wank R; Hansen JA; Dupont B
    Transplant Proc; 1977 Dec; 9(4):1777-80. PubMed ID: 74883
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated lympholysis in man: CML specificities and their possible relevance.
    Kristensen T
    Transplant Proc; 1978 Jun; 10(2):319-25. PubMed ID: 79254
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression.
    Suranyi MG; Waugh J; Bishop GA; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):417-20. PubMed ID: 2950620
    [No Abstract]   [Full Text] [Related]  

  • 4. Retention of DR-specific memory in primed lymphocytes grown in PHA-conditioned media.
    Brown S; Maca R; Klassen L; Goeken N; Severson C; Thompson J
    Transplant Proc; 1979 Dec; 11(4):1982-5. PubMed ID: 93819
    [No Abstract]   [Full Text] [Related]  

  • 5. A functional assay of HLA-directed non-T-cell mediated lympholysis (CML).
    Goeken NE; Thompson JS
    Transplant Proc; 1978 Dec; 10(4):943-6. PubMed ID: 153620
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary cell-mediated lympholysis in man.
    Singal DP; Wadia YJ; Naipaul N
    Transplant Proc; 1978 Dec; 10(4):929-31. PubMed ID: 83726
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA CD antigen crossmatching--the pool cell-mediated lympholysis test.
    Martinis J; Bach FH
    Transplantation; 1978 Jan; 25(1):39-41. PubMed ID: 145676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of histocompatibility using cell-mediated lympholysis].
    Potmĕsilová I; Soucek J; Novák JT
    Vnitr Lek; 1980 Nov; 26(11):1072-8. PubMed ID: 6455007
    [No Abstract]   [Full Text] [Related]  

  • 9. Histocompatibility and natural cell-mediated cytotoxicity.
    Takasugi M; Koide Y; Takasugi J; Akira D; Opelz G
    Transplant Proc; 1979 Jun; 11(2):1332-3. PubMed ID: 157571
    [No Abstract]   [Full Text] [Related]  

  • 10. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 11. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP; du Bois MJ; Meinesz A; Bierhorst-Eijlander A; Zeylemaker WP; Schellekens PT
    Transplant Proc; 1973 Dec; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract]   [Full Text] [Related]  

  • 12. Target antigens of cell-mediated lympholysis discrimination of HLA subtypes by cytotoxic lymphocytes.
    Robinson MA; Noreen HJ; Amos DB; Yunis EJ
    J Immunol; 1978 Oct; 121(4):1486-90. PubMed ID: 701804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primed lymphocyte typing in man.
    Morling N
    Dan Med Bull; 1983 May; 30(3):158-76. PubMed ID: 6190618
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated lympholysis--problems and possibilities in defining specificities.
    Ward MJ; Stiller CR; McGirr DA; Fung M; Cousin HK; Paty DW; Howson WT; Sinclair NR
    Transplant Proc; 1977 Dec; 9(4):1781-6. PubMed ID: 74884
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture.
    Callewaert DM; Lightbody JJ; Kaplan J; Jaroszewski J; Peterson WD; Rosenberg JC
    J Immunol; 1978 Jul; 121(1):81-5. PubMed ID: 149818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous cell-mediated cytotoxicity and generation of HLA-unrelated cytotoxic effector cells during MLC in vitro.
    Leibold W; Gatti RA; Just S; Peter HH
    Transplant Proc; 1979 Jun; 11(2):1393-9. PubMed ID: 157578
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell mediated lympholysis: effect of papain on effector and target cells.
    Lightbody JJ; Bach FH
    Ann Immunol (Paris); 1973 Aug; 124(3):311-9. PubMed ID: 4272624
    [No Abstract]   [Full Text] [Related]  

  • 18. DRw determinants on human T cells primed against allogeneic lymphocytes.
    Suciu-Foca N; Susinno E; McKiernan P; Rohowsky C; Weiner J; Rubinstein P
    Transplant Proc; 1978 Dec; 10(4):845-8. PubMed ID: 83718
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression.
    Suranyi MG; Bishop GA; Waugh J; Hall BM
    Transplant Proc; 1987 Apr; 19(2):2869-72. PubMed ID: 3551229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.